![Mark Warne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Warne
Vorstandsvorsitzender bei
DEEPMATTER GROUP PLC
Vermögen: 26 020 $ am 31.08.2026
Profil
Mark Robert Warne is Chief Executive Officer & Executive Director at ChemAI Ltd. since 2018, Non-Executive Chairman at Ixico Plc since 2016, Healthcare Portfolio Director at IP Group Plc, Non-Executive Director at hVIVO Services Ltd. since 2016, Director at DegraSense Ltd., Director at Genomics Ltd., Member of The Royal Society of Chemistry, and Advisor at Angelini Ventures SpA. Former roles include Chief Executive Officer & Director at Activiomics Ltd. from 2011 to 2013, Director at Azellon Ltd., Non-Executive Director at hVIVO Holdings Ltd., Managing Director at Receptor Research Ltd., Director at Capsant Neurotechnologies Ltd., Non-Executive Director at Crysalin Ltd., Director at Iksuda Therapeutics Ltd., Director at Ubiquigent Ltd., Non-Executive Director at Optimal Medicine Ltd., Independent Non-Executive Director at hVIVO PLC in 2020, and Head-Life Science Division at IP Group Plc.
Education includes undergraduate, graduate, and doctorate degrees from the University of Bristol.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IXICO PLC 0.11% | 15.07.2026 | 247’341 ( 0.11% ) | 26 020 $ | 31.08.2026 |
Aktive Positionen von Mark Warne
| Unternehmen | Position | Beginn |
|---|---|---|
| DEEPMATTER GROUP PLC | Vorstandsvorsitzender | 02.07.2018 |
| IXICO PLC | Vorsitzender | - |
Angelini Ventures SpA
 Angelini Ventures SpA Investment ManagersFinance Angelini Ventures invests in companies located in North America, Europe, Israel and Italy. The firm focuses on digital healthcare, connected medical devices and life sciences. It participates in early stage capital requirements. | Berater | - |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases | Direktor/Vorstandsmitglied | 01.04.2016 |
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Develops research and experimental development on biotechnology | Direktor/Vorstandsmitglied | - |
DegraSense Ltd. | Direktor/Vorstandsmitglied | - |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | 16.03.2011 |
IP Group Plc /Venture Capital/
 IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group invests in companies located in the United Kingdom, United States and Australia. The firm targets companies operating in the fileds of life sciences, deeptech and cleantech. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Mark Warne
| Unternehmen | Position | Ende |
|---|---|---|
| HVIVO PLC | Direktor/Vorstandsmitglied | 31.12.2020 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Mark Warne
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
20
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 20 |
|---|---|
hVIVO Holdings Ltd.
 hVIVO Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Ixico Plc
 Ixico Plc Miscellaneous Commercial ServicesCommercial Services Operates as a medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics | Commercial Services |
IP Group Plc
 IP Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property commercialization and venture capital fund management company | Commercial Services |
Receptor Research Ltd.
 Receptor Research Ltd. Chemicals: Major DiversifiedProcess Industries Provides drug discovery informatics products and services | Process Industries |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capsant Neurotechnologies Ltd.
 Capsant Neurotechnologies Ltd. Pharmaceuticals: MajorHealth Technology Provides pre-clinical assay services to the drug development industry | Health Technology |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions | Technology Services |
Azellon Ltd.
 Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapy for the repair of avascular meniscal tears | Commercial Services |
Crysalin Ltd.
 Crysalin Ltd. BiotechnologyHealth Technology Develops technology for protein structure determination | Health Technology |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Provides clinical development services for antibody-drug conjugate | Health Technology |
Activiomics Ltd.
 Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides high value information for the pharmaceutical and biotechnology industry | Commercial Services |
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases | Technology Services |
IP Group Plc /Venture Capital/
IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group invests in companies located in the United Kingdom, United States and Australia. The firm targets companies operating in the fileds of life sciences, deeptech and cleantech. It provides financing for early stage capital requirements. | Finance |
DegraSense Ltd. | |
Ubiquigent Ltd.
 Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Develops reagents, kits, drug discovery assay development and compound profiling services | Commercial Services |
Optimal Medicine Ltd.
 Optimal Medicine Ltd. Packaged SoftwareTechnology Services Offers individualized clinical decision support software for mental health disorders | Technology Services |
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Develops research and experimental development on biotechnology | Health Technology |
hVIVO PLC
 hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services | Commercial Services |
Angelini Ventures SpA
Angelini Ventures SpA Investment ManagersFinance Angelini Ventures invests in companies located in North America, Europe, Israel and Italy. The firm focuses on digital healthcare, connected medical devices and life sciences. It participates in early stage capital requirements. | Finance |
